포유류 세포 발효 기술 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global mammalian cell fermentation technology market size is expected to reach USD 127.33 Billion in 2034 from USD 57.29 Billion in 2025, growing at a CAGR of 9.28% during 2026-2034.The Mammalian Cell Fermentation Technology Market is poised for significant growth as the demand for biopharmaceuticals and biologics continues to rise. Mammalian cell fermentation is a critical process in the production of therapeutic proteins, monoclonal antibodies, and vaccines, making it essential for the biopharmaceutical industry. The increasing prevalence of chronic diseases and the growing focus on personalized medicine are driving investments in mammalian cell fermentation technologies, further propelling market expansion.

Technological advancements are playing a crucial role in shaping the future of the mammalian cell fermentation technology market. Innovations in bioreactor design, cell culture media, and process optimization are enhancing the efficiency and scalability of mammalian cell fermentation processes. Additionally, the integration of automation and data analytics is improving the monitoring and control of fermentation processes, enabling higher yields and reduced production times. As manufacturers continue to innovate and develop new solutions, the mammalian cell fermentation technology market is likely to see increased adoption across various biopharmaceutical applications.

Moreover, the growing emphasis on regulatory compliance and quality assurance is influencing the mammalian cell fermentation technology market's growth trajectory. As regulatory agencies implement stricter guidelines for biopharmaceutical production, the demand for fermentation technologies that meet these standards is expected to rise. This trend is driving collaboration between technology providers and biopharmaceutical companies to develop integrated solutions that ensure compliance and enhance product quality. As the market continues to evolve, the integration of technology, regulatory compliance, and quality management will be key drivers of success.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

• Chinese Hamster Ovary (CHO) Cell Fermentation
• Human Embryonic Kidney (HEK) Cell Fermentation
• Baby Hamster Kidney (BHK) Cell Fermentation
• Murine Myeloma Cell Fermentation
• Others

By Application

• Monoclonal Antibodies
• Recombinant Proteins
• Vaccines
• Hormones
• Enzymes
• Others

By End-Use

• Biopharmaceutical Companies
• CMOs & CDMOs
• Academic & Research Institutes

COMPANIES PROFILED

• Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Lonza Group Ltd., Roche Holding AG, Sartorius AG, AstraZeneca PLC, Bristol Myers Squibb Company, Amgen Inc., Gilead Sciences, Inc., Moderna, Inc., Regeneron Pharmaceuticals, Inc., AGC Biologics, Boehringer Ingelheim, Catalent, Inc., Samsung Biologics Co., Ltd., WuXi Biologics, Biocon Limited, FUJIFILM Diosynth Biotechnologies, KBI Biopharma, Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Chinese Hamster Ovary (CHO) Cell Fermentation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Human Embryonic Kidney (HEK) Cell Fermentation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Baby Hamster Kidney (BHK) Cell Fermentation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Murine Myeloma Cell Fermentation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Monoclonal Antibodies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Recombinant Proteins Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Hormones Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Enzymes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Biopharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. CMOs & CDMOs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Spain
  • 7.3.9 Russia
  • 7.3.10 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 China
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 India
  • 7.4.8 Australia
  • 7.4.9 South East Asia
  • 7.4.10 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Merck KGaA
  • 9.2.3 Danaher Corporation
  • 9.2.4 Lonza Group Ltd
  • 9.2.5 Roche Holding AG
  • 9.2.6 Sartorius AG
  • 9.2.7 AstraZeneca PLC
  • 9.2.8 Bristol Myers Squibb Company
  • 9.2.9 Amgen Inc
  • 9.2.10 Gilead SciencesInc
  • 9.2.11 ModernaInc
  • 9.2.12 Regeneron PharmaceuticalsInc
  • 9.2.13 AGC Biologics
  • 9.2.14 Boehringer Ingelheim
  • 9.2.15 CatalentInc
  • 9.2.16 Samsung Biologics Co.Ltd
  • 9.2.17 WuXi Biologics
  • 9.2.18 Biocon Limited
  • 9.2.19 FUJIFILM Diosynth Biotechnologies
  • 9.2.20 KBI BiopharmaInc